子宫内膜异位症、动脉粥样硬化性心血管疾病与中年女性健康之间的关联
本文综述子宫内膜异位症与动脉粥样硬化性心血管疾病(ASCVD)的关联机制,指出两者均以炎症为核心,现有证据提示确诊子宫内膜异位症的年轻女性终生心血管疾病风险可能更高,作者认为应将子宫内膜异位症病史纳入ASCVD风险评估并进一步探索。
要点
- 子宫内膜异位症与ASCVD均以炎症为基本病理过程,炎症是血管损伤和动脉粥样硬化的核心机制。
- 现有证据提示确诊子宫内膜异位症的年轻女性终生心血管疾病风险可能更高,但可能因年龄较轻而被忽视。
- 作者认为评估女性ASCVD风险时,应将子宫内膜异位症病史作为可能的风险因素纳入并进一步探索。
核心结论
- 子宫内膜异位症与ASCVD均以炎症为核心机制,确诊子宫内膜异位症的年轻女性终生心血管疾病风险可能更高。
- 作者认为应将子宫内膜异位症病史作为ASCVD的可能风险因素纳入评估,并需进一步探索。
研究设计与样本
- 综述,检索范围原文未报告。
主要发现
- 炎症是血管损伤启动与维持以及动脉粥样硬化发生发展的主导机制。
- 若子宫内膜异位症女性确实存在全身炎症增加,则其发生微血管功能障碍和动脉粥样硬化的风险增加。
- 现有证据提示确诊子宫内膜异位症的年轻女性终生心血管疾病风险可能更高,可能因患者年龄较轻而未被识别。
- 其他解释关联的机制包括两种疾病遗传基础的相似性(含microRNA功能异常)以及子宫内膜异位症与早绝经的关联,而早绝经是ASCVD的风险因素。
临床怎么用
- 目前医生评估女性个体ASCVD风险时主要关注传统危险因素,作者认为应将子宫内膜异位症病史作为可能的风险因素纳入并需进一步探索。
- 作者希望更好地理解子宫内膜异位症与ASCVD的关联机制,以指导实施新疗法来减轻子宫内膜异位症患者可能面临的增加的心血管疾病负担。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Endometriosis and atherosclerotic cardiovascular disease (ASCVD) are both essentially diseases of inflammation. It is well established that inflammation is the leading mechanism in the initiation and maintenance of vascular injury and in the development and progression of atherosclerosis. Thus, if women with endometriosis do indeed have increased general inflammation, they are at increased risk of developing microvascular dysfunction and atherosclerosis. Currently available evidence suggests that young female patients with proven endometriosis may be at a higher lifetime risk of developing cardiovascular disease; this may be unrecognized due to the relatively young age of women found to have endometriosis. Other mechanisms proposed to explain the link between endometriosis and ASCVD include similarities in the genetic underpinnings of each condition, including microRNA dysfunction and the association between endometriosis and early menopause, a risk for developing ASCVD. Although physicians today primarily focus on traditional risk factors when evaluating an individual female patient's risk of developing ASCVD, we believe that a history of endometriosis should be included as a possible risk factor and needs further exploration. A better understanding of the mechanisms linking endometriosis with ASCVD will hopefully guide the implementation of new therapies to mitigate the increased cardiovascular disease burden that patients with endometriosis might face.
引用
- Taskin O, Rikhraj K, Tan J, et al. Link between Endometriosis, Atherosclerotic Cardiovascular Disease, and the Health of Women Midlife. J Minim Invasive Gynecol. 2019. PMID: 31028947. doi:10.1016/j.jmig.2019.02.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。